Lilly just announced that the FDA has approved its Humalog 200 units/mL KwikPen (insulin lispro) for type 1 and type 2 diabetes, making it the first concentrated mealtime insulin analog to reach the US market.
FDA Approves First-Ever Concentrated Mealtime Insulin
Posted in Glucose & Insulin